Erlotaz 150 Tablet
Marketer
Khandelwal Laboratories Pvt Ltd
Salt Composition
Erlotinib (150mg)
Overview Erlotaz 150 Tablet
Erlotaz 150mg tablets treat non-small cell lung and pancreatic cancers. Administer on an empty stomach, or one hour before or two hours after eating. Continue treatment as directed by your physician; duration depends on individual response. Follow your doctor's instructions precisely; incorrect usage or overdose can cause severe adverse reactions. Therapeutic benefits might not be apparent for weeks or months; do not discontinue without medical advice. Common side effects include nausea, vomiting, tiredness, skin rash, and weight loss. Severe diarrhea necessitates increased fluid intake or medical consultation. Photosensitivity is possible; wear protective clothing and sunscreen outdoors. Report mouth sores, vision changes, or breathing problems immediately. Regular liver function monitoring may be required. Inform your healthcare provider of all other medications you are taking, as interactions are possible. This medication is contraindicated during pregnancy and breastfeeding; reliable contraception is essential for both partners. Smoking cessation is advisable during treatment due to potential drug interactions. Maintain a two-hour interval between Erlotaz and antacids or other medications.
Primary Ingredients of Erlotaz 150 Tablet
The provided text is "undefined," which lacks meaning and cannot be rephrased. Therefore, no rewritten text can be provided.
Uses of Erlotaz 150 Tablet
Cancers of the pancreas and non-small cell lung
Major Benefits of Erlotaz 150 Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Erlotaz 150 Tablet on an empty stomach.
Common Side effects of Erlotaz 150 Tablet:
- Abdominal pain
- Bone pain
- Breathlessness
- Constipation
- Cough
- Diarrhea
- Fatigue
- Fever
- Infection
- Muscle pain
- Nausea
- Rash
- Stomatitis (Inflammation of the mouth)
- Vomiting
- Weight loss
How to use Erlotaz 150 Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Erlotaz 150 Tablet on an empty stomach.
How Erlotaz 150 Tablet works:
Erlotaz 150 mg tablets are used in cancer treatment. Lung cancer cells possess epidermal growth factor receptors (EGFRs) which regulate their proliferation. This drug functions by attaching to these EGFRs, thereby blocking the cancer-related signaling processes they control and consequently limiting further tumor development.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Erlotaz 150 Tablet is of uncertain safety. Physician consultation is advised.
PregnancyCONSULT YOUR DOCTOR
Use of Erlotaz 150 Tablet during pregnancy poses a confirmed risk to the fetus and is therefore inadvisable. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingCONSULT YOUR DOCTOR
Breastfeeding while taking Erlotaz 150mg tablets is likely inadvisable. Studies in humans indicate a potential for the medication to transfer to breast milk, posing a risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Erlotaz 150 Tablet on driving ability is undetermined. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
For individuals with kidney impairment, Erlotaz 150 Tablet is considered safe, requiring no dosage modification. However, its use is contraindicated in patients exhibiting severe kidney disease.
LiverCAUTION
Patients with liver impairment should exercise caution when using Erlotaz 150mg tablets. Dosage modification may be necessary; physician consultation is advised.
What if you forget to take Erlotaz 150 Tablet :
Omit any missed Erlotaz 150 Tablet dose and resume your usual medication regimen; avoid taking a double dose.
Facts to Know About Erlotaz 150 Tablet
| Label | Value |
|---|---|
| Chemical Category | Quinazoline-based compound |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |


